Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States.

Harlan LC, Clegg LX, Trimble EL.

J Clin Oncol. 2003 Sep 15;21(18):3488-94.

PMID:
12972525
2.

Patterns of chemotherapy use for women with ovarian cancer: a population-based study.

Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL.

J Clin Oncol. 2003 Apr 15;21(8):1530-5.

PMID:
12697877
3.

Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.

Cronin DP, Harlan LC, Potosky AL, Clegg LX, Stevens JL, Mooney MM.

Am J Gastroenterol. 2006 Oct;101(10):2308-18.

PMID:
17032196
4.

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

Goff BA, Matthews BJ, Larson EH, Andrilla CH, Wynn M, Lishner DM, Baldwin LM.

Cancer. 2007 May 15;109(10):2031-42.

5.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

PMID:
18364506
6.

Insurance status and the use of guideline therapy in the treatment of selected cancers.

Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML.

J Clin Oncol. 2005 Dec 20;23(36):9079-88. Epub 2005 Nov 21.

PMID:
16301598
7.

The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?

Shone LP, Dick AW, Brach C, Kimminau KS, LaClair BJ, Shenkman EA, Col JF, Schaffer VA, Mulvihill F, Szilagyi PG, Klein JD, VanLandeghem K, Bronstein J.

Pediatrics. 2003 Dec;112(6 Pt 2):e521.

PMID:
14654674
8.
9.

Ovarian cancer: patterns of surgical care across the United States.

Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM.

Gynecol Oncol. 2006 Nov;103(2):383-90. Epub 2006 Sep 26.

PMID:
17005244
10.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

PMID:
19273706
11.

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW.

J Natl Cancer Inst. 2005 Oct 5;97(19):1407-27.

PMID:
16204691
12.

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.

Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL.

J Natl Cancer Inst. 2006 Feb 1;98(3):172-80.

PMID:
16449677
13.

Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Shugarman LR, Mack K, Sorbero ME, Tian H, Jain AK, Ashwood JS, Asch SM.

Med Care. 2009 Jul;47(7):774-81. doi: 10.1097/MLR.0b013e3181a393fe.

PMID:
19536007
14.

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R.

J Clin Oncol. 2006 Feb 20;24(6):872-7.

PMID:
16484696
15.

Breast cancer treatment among women of different ethnicity in Hawaii.

Issell BF, Maskarinec G, Pagano I, Gotay CC.

Cancer Invest. 2005;23(6):497-504.

PMID:
16203657
16.

Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity.

Naeim A, Hurria A, Leake B, Maly RC.

Crit Rev Oncol Hematol. 2006 Sep;59(3):234-42. Epub 2006 Jul 10.

PMID:
16829122
17.

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J.

J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.

PMID:
22147735
18.

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

Keating NL, Kouri E, He Y, Weeks JC, Winer EP.

Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7.

PMID:
19536008
19.

Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data.

Yancik R, Ries LG, Yates JW.

Am J Obstet Gynecol. 1986 Mar;154(3):639-47.

PMID:
3953714
20.

Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer.

Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C.

Gynecol Oncol. 2008 Jan;108(1):95-9. Epub 2007 Oct 18.

PMID:
17949796

Supplemental Content

Support Center